Hôpital Européen Georges Pompidou - AP-HP

51 currently recruiting clinical trials
Create patient profile for matching
Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT06475352
Locally Advanced Metastatic None Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
UNICANCER
Phase 2 Colon cancer Rectal cancer #NCT05706779
Adenocarcinoma Localized BRAF None Systemic Treatment-Naive
KRAS G12C KRAS non G12C NRAS Targeted therapy
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Fédération Francophone de Cancérologie Digestive
Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT04617756
Upper excretory tract cancer Urothelial carcinoma Localized None Systemic Treatment-Naive
Surgery
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Centre Hospitalier Universitaire de Nîmes
Phase 1 / Phase 2 Stomach and esophageal cancer Sarcoma and GIST #NCT05957367 #2024-516476-15-00
Module B Partie 2
GIST Gastrointestinal stromal tumor Locally Advanced Metastatic KIT 1 Targeted therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Deciphera Pharmaceuticals, LLC
Phase 1 / Phase 2 Stomach and esophageal cancer Sarcoma and GIST #NCT05957367 #2024-516476-15-00
Module B Partie 1
GIST Gastrointestinal stromal tumor Locally Advanced Metastatic KIT PDGFRA 1 2 3 or more
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Deciphera Pharmaceuticals, LLC
Phase 1 / Phase 2 Prostate cancer #NCT07206056 #2025-521880-10-00
Adenocarcinoma Metastatic Castration-resistant 1 2 3 or more Hormone therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Novartis
Phase 1 / Phase 2 Prostate cancer #NCT06353386 #2023-506288-33-00
Adenocarcinoma Metastatic Castration-resistant 1 2 3 or more Hormone therapy Hormone therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Merck Sharp & Dohme LLC
Phase 1 Breast cancer Lung cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05403554 #2021-003808-40
Cohorte monothérapie
NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer Non-squamous NSCLC Serous high grade carcinoma (HGSOC) Endometrioid carcinoma HER2 Negative HER2 Positive Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Light Chain Bioscience - Novimmune SA
Phase 1 Lung cancer Pancreas cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05403554 #2021-003808-40
Cohorte d'association avec le pembrolizumab
NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer Non-squamous NSCLC Adenocarcinoma Serous high grade carcinoma (HGSOC) Endometrioid carcinoma Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Light Chain Bioscience - Novimmune SA
Phase 1
Matches all main criterias
Hôpital Européen Georges Pompidou - AP-HP (Paris)